ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
18.704,42
-0,11%
S&P 500
5.303,27
0,12%
Dow Jones
40.003,59
0,34%
Euro vs US Dollar
1,08955
0,00%
Bitcoin
66.800,80
-0,42%
Registration Strip Icon for alerts Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. Kanada
  5. TSXV
  6. Theralase Technologies Inc (TLT)

  7. Theralase Technologies Inc (TLT) News

TLT

Theralase Technologies (TLT)

Theralase Technologies Inc
Von:
Sortieren nach:
 Showing the most relevant articles for your search:TSXV:TLT
DatumZeitQuelleÜberschriftSymbolFirma
14/02/202406h39PR Newswire (Canada)24/02/13 - TSX Venture Exchange Stock Maintenance BulletinsTSXV:TLTTheralase Technologies Inc
06/01/202300h03PR Newswire (Canada)TSX Venture Exchange Stock Maintenance BulletinsTSXV:TLTTheralase Technologies Inc
13/11/202018h49PR Newswire (Canada)L'OCRCVM permet la reprise de la négociation - TLTTSXV:TLTTheralase Technologies Inc
13/11/202018h47PR Newswire (Canada)IIROC Trading Resumption - TLTTSXV:TLTTheralase Technologies Inc
13/11/202017h22PR Newswire (Canada)Suspension de la négociation par l'OCRCVM - TLTTSXV:TLTTheralase Technologies Inc
13/11/202017h20PR Newswire (Canada)IIROC Trading Halt - TLTTSXV:TLTTheralase Technologies Inc
08/01/202021h30PR Newswire (Canada)View from the C-Suite: Shawn Shirazi, Chief Executive Officer, Theralase Technologies Inc., tells his company's story. Filmed...TSXV:TLTTheralase Technologies Inc
13/11/201719h20PR Newswire (Canada)L'OCRCVM permet la reprise de la négociation - TLTTSXV:TLTTheralase Technologies Inc
13/11/201719h19PR Newswire (Canada)IIROC Trading Resumption - TLTTSXV:TLTTheralase Technologies Inc
13/11/201717h33PR Newswire (Canada)Suspension de la négociation par l'OCRCVM - TLTTSXV:TLTTheralase Technologies Inc
13/11/201717h29PR Newswire (Canada)IIROC Trading Halt - TLTTSXV:TLTTheralase Technologies Inc
24/06/201412h59Access WireTheralase Releases Peer-Reviewed Research on Anti-Cancer Memory Response and Destruction of Cancerous CellsTSXV:TLTTheralase Technologies Inc
18/06/201412h59Access WireTheralase Partners with University of Toledo in Cancer ResearchTSXV:TLTTheralase Technologies Inc
12/06/201412h59Access WireTheralase Stock Upgraded on US OTC MarketTSXV:TLTTheralase Technologies Inc
05/06/201412h59Access WireTheralase CEO Interviewed by CBC TV about Progress in Anti-Cancer and Pain ResearchTSXV:TLTTheralase Technologies Inc
05/06/201412h59Access WireTheralase CEO Interviewed by CBC TV about Progress in Anti-Cancer and Pain ResearchTSXV:TLTTheralase Technologies Inc
05/06/201412h59Access WireTheralase CEO Interviewed by CBC TV about Progress in Anti-Cancer and Pain ResearchTSXV:TLTTheralase Technologies Inc
05/06/201412h59Access WireTheralase CEO Interviewed by CBC TV about Progress in Anti-Cancer and Pain ResearchTSXV:TLTTheralase Technologies Inc
05/06/201412h59Access WireTheralase CEO Interviewed by CBC TV about Progress in Anti-Cancer and Pain ResearchTSXV:TLTTheralase Technologies Inc
05/06/201412h59Access WireTheralase CEO Interviewed by CBC TV about Progress in Anti-Cancer and Pain ResearchTSXV:TLTTheralase Technologies Inc
05/06/201412h59Access WireTheralase CEO Interviewed by CBC TV about Progress in Anti-Cancer and Pain ResearchTSXV:TLTTheralase Technologies Inc
30/05/201423h12Access WireTheralase Releases 1Q2014 Financial ResultsTSXV:TLTTheralase Technologies Inc
29/05/201412h59Access WireTheralase Discovers Anti-Cancer Memory ResponseTSXV:TLTTheralase Technologies Inc
27/05/201412h59Access WireTheralase Anti-Cancer Technology Validated in Prestigious US Chemistry PublicationTSXV:TLTTheralase Technologies Inc
15/05/201413h00Access WireTheralase Partners with Princess Margaret Cancer CentreTSXV:TLTTheralase Technologies Inc
15/05/201413h00Access WireTheralase Partners with Princess Margaret Cancer CentreTSXV:TLTTheralase Technologies Inc
15/05/201413h00Access WireTheralase Partners with Princess Margaret Cancer CentreTSXV:TLTTheralase Technologies Inc
30/04/201422h28Access WireTheralase Releases 2013 FinancialsTSXV:TLTTheralase Technologies Inc
24/04/201412h59Access WireTheralase Anti-Cancer Technology Validated at International ConferenceTSXV:TLTTheralase Technologies Inc
22/04/201412h59Access WireTheralase Research Accepted at International ConferenceTSXV:TLTTheralase Technologies Inc
 Showing the most relevant articles for your search:TSXV:TLT

Kürzlich von Ihnen besucht

COIN
UNRCGBP
COIN
AGBETH
AGBCoin
COIN
XLMJPY
Stellar Lumens
EU
1247T
1247T
BOV
ABCB4M
ABC BRASIL PN
USOTC
SCTSF
Scottie Resources (QB)
AMEX
GCAD
Gabelli Commercial Aeros...
AMEX
BKR
Bank Restaurant
COIN
XGSGBP
LSE
DGOC
Diversified Gas & Oil
NYSE
CTLT
Catalent
COIN
EXPIUSD
EU
F933S
F933S
TG
BSS
Beta Systems Software
LSE
JPSR
Ubsetf Jpsr
USOTC
SIMTF
Sim Technology (PK)
Delayed Upgrade Clock
ADVFN Logo

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten